PATENT CLAIM ANALYSIS

Application Number: 16326513
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "051000"]

Abstract:
Methods and compounds are disclosed for irreversibly inhibiting a DNA repair enzyme that possesses lyase activity.

Claim (Index 13):
The method of  claim 12 , further comprising treating, inhibiting, delaying, or preventing the spread of the cancer by inhibiting at least one cancer cell involved in one or more biological processes selected from the group consisting of cell migration, cell growth, cell adhesion, angiogenesis, cancer cell invasion, apoptosis, tumor formation, tumor progression, metastasis, degradation of the extracellular matrix, pericellular proteolysis, activation of plasminogen, and changes in the levels of an extracellular protease.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14106016', '15342175', '10337012', '10505400', '13891067']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6932784267497396
- 35 USC 102 Novelty (BERT): 0.5623094793496496
- Combined Prediction Score: 0.6801815320097306
- Mean Citation Score: 251.44748600000003
- Max Citation Score: 429.80917
- Similarity Product: 341.2231231056827

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test